A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2- expressing murine sarcomas

Cancer Research

Volumn 58, Issue 15, 1998, Pages 3385-3390

  Gu, Xiao Gang ^a,e   Schmitt, Michael ^a,f   Hiasa, Atsunori ^a   Nagata, Yasuhiro ^b   Ikeda, Hiroaki ^a   Sasaki, Yoshihiro ^c   Akiyoshi, Kazunari ^c   Sunamoto, Junzo ^c   Nakamura, Hideo ^d   Kuribayashi, Kagemasa ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d MITSUBISHI CHEMICAL CORPORATION   (Japan)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD3 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G; ONCOPROTEIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINE PRODUCTION;

ANIMALS; ANTIBODY FORMATION; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GLUCANS; LYMPHOCYTE ACTIVATION; MANNANS; MICE; MICE, INBRED BALB C; RECEPTOR, ERBB-2; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 10744224107     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Van der Eynde, B. P., Basti, J., Gajewski, T., Coulie, P. G., Boël, P., Desmet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
2. Boon, T., and Van der Eynde, B. P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
3. Apostolopoulos, V., Pietersz, G. A., Loveland, B. E., Sandrin, M. S., and McKenzie, I. F. C. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc. Natl. Acad. Sci. USA, 92: 10128-10132, 1995.
4. Fenton, R. G., Taub, D. D., Kwak, L. W., Smith, M. R., and Longo, D. L. Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes. J. Natl. Cancer Inst., 85: 1294-1301, 1993.
5. Schirmbeck, R., Böhm, W., and Reimann, J. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur. J. Immunol., 24: 2068-2072, 1994.
6. Noguchi, Y., Noguchi, T., Sato, T., Yokoo, Y., Itoh, S., Yoshida, M., Yoshiki, T., Akiyoshi, K., Sunamoto, J., Nakayama, E., and Shiku, H. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome. J. Immunol., 146: 3599-3603, 1991.
7. Disis, M. L., Gralow, J. R., Bernhard, H., Hand, S. L., Rubin, W. D., and Cheever, M. A. Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, an oncogenic self-protein. J. Immunol., 156: 3151-3158, 1996.
8. + cytotoxic T-cell responses? A paradox revisited. Immunol. Today, 14: 344-348, 1993.
9. Malik, A., Gross, M., Ulrich, T., and Hoffman, S. L. Induction of cytotoxic T lymphocytes against the plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant. Infect. Immun., 61: 5062-5066, 1993.
10. Harris, N., Super, M., Rits, M., Chang, G., and Ezekowitz, R. A. B. Characterization of the murine macrophage mannose receptor: demonstration that the down-regulation of receptor expression mediated by interferon-γ occurs at the level of transcription. Blood, 80: 2363-2373, 1992.
11. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., and Nussenzweig, M. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (Lond.), 375: 151-155, 1995.
12. Akiyoshi, K., and Sunamoto, J. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristic of nanoparticles. Macromolecules, 26: 3062-3068, 1993.
13. Akiyoshi, K., and Sunamoto, J. Supramolecular assembly of hydrophobized polysaccharide. Supramolecular Sci., 3: 157-163, 1996.
14. Nishikawa, T., Akiyoshi, K., and Sunamoto, J. Macro-molecular complexation between bovine serum albumin and self-assembled hydrogel nanoparticle of hydrophobized polysaccharides. J. Am. Chem. Soc., 18: 6110-6115, 1996.
15. Slamon, D. J., Godolphin, W. L., Jones, A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., and Ullrich, A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
16. Wright, C., Mellon, K., Neal, D. E., Johnston, P., Corbett, I. P., and Horne, C. H. Expression of c-erbB-2 protein product in bladder cancer. Br. J. Cancer, 62: 764-765, 1990.
17. Berchuck, A., Rodriguez, G. R., Kinney, B., Soper, J. T., Dodge, R. K., Clarke-Pearson, D. L., and Bast, R. C., Jr. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am. J. Obstet. Gynecol., 164: 15-21, 1991.
18. Yonemura, Y., Ninomiya, I., Yamaguchi, A., Fushida, S., Kimura, H., Ohoyama, S., Miyazaki, I., Endou, Y., Tanaka, M., and Sasaki, T. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short-term prognosis in gastric cancer. Cancer Res., 51: 1034-1038, 1991.
19. Becker, J., and Loning, T. Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer (Phila.), 67: 2142-2149, 1991.
20. Nagata, Y., Oshikubo, R., Hiasa, A., Ikeda, H., Ohta, N., Furukawa, K., Nakamura, H., Kanematsu, T., and Shiku, H. Peptides derived from a wild-type murine proto-oncogene c-erbB2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. J. Immunol., 159: 1336-1343, 1997.
21. DeLeo, A. B., Shiku, H., Takahashi, T., John, M., and Old, L. J. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med., 146: 720-734, 1977.
22. VanPel, A., De Plaen, E., and Boon, T. Selection of highly transfectable variant from mouse mastocytoma P815. Somat. Cell Mol. Genet., 11: 467-475, 1985.
23. Ikeda, H., Ohta, N., Furukawa, K., Miyazaki, H., Wang, L., Furukawa, K., Kuribayashi, K., Old, L. J., and Shiku, H. Mutated MAP kinase. A tumor rejection antigen of mouse sarcoma. Proc. Natl. Acad. Sci. USA, 94: 6375-6379, 1997.
24. Coussens, L., Yang-Feng, T. L., Liao, Y. C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., Levinson, A., and Ullrich, A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (Washington DC), 230: 1132-1139, 1985.
25. Schmitt, M., Ikeda, H., Nagata, Y., Gu, X., Wang, L., Kuribayashi, K., and Shiku, H. Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes. Int. J. Cancer, 72: 505-511, 1997.
26. + T cells in vivo. Proc. Natl. Acad. Sci. USA, 91: 3077-3081, 1994.
27. Mayordomo, J. I., Zorine, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Kast, W. M., and DeLeo, A. B. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med., 1: 1297-1302, 1995.
28. Newman, M. J., Wu, J., Gardner, B. H., Munroe, K. J., Leombruno, D., Recchia, J., Kensil, C. R., and Coughlin, R. T. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J. Immunol., 148: 2357-2362, 1992.
29. Alving, C. R. Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity. Ann. N. Y. Acad. Sci., 754: 143-152, 1995.
30. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature (Lond.), 344: 873-875, 1990.
31. Zhou, F., and Huang, L. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen trapped in liposomes. Vaccine, 11: 1139-1144, 1993.
32. Kang, E-C., Akiyoshi, K., and Sunamoto, J. Surface coating of liposomes with hydrophobized polysaccharides. J. Bioact. Compat. Polym., 12: 14-26, 1997.
33. Akiyoshi, K., and Sunamoto, J. Physicochemical characterization of cholesterol-bearing polysaccharides in solution. In: S. E. Freiberg and B. Lindman (eds.), Organized Solutions. Surfactants in Science and Technology, pp. 289-304. New York: Marcel Dekker, Inc., 1992.
34. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecule in the major histocompatibility class II compartment: down-regulation by cytokines and bacterial products. J. Exp. Med., 182: 389-400, 1995.